Stockscreener 앱 받기
1.24
24.45%
0.2436
시간 외 거래:
1.26
0.02
+1.61%
China Pharma Holdings Inc. 주식(CPHI)의 최신 뉴스
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity - digitalmore.co
China Pharma says unaware of reason for unusual trading - Investing.com
China Pharma Holdings IncNYSE American contacts China Pharma regarding unusual market activity on May 12 and 13 - marketscreener.com
China drugmaker sees unusual stock activity, reports no new info - Stock Titan
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
TradingKey - TradingKey
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
These stocks are moving in today's after hours session - ChartMill
C3 AI Announces Q4 and Fiscal Year 2026 Preliminary Results: Tom Siebel Returns as CEO, Reports Revenue Within Guidance and Improved Operating Losses - Minichart
CPHI Stock Price, Quote & Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
CPHI PE Ratio & Valuation, Is CPHI Overvalued - Intellectia AI
China NT Pharma Group Quarterly Update on Action Plans for Disclaimer of Opinion Resolution and AI Health Business Transformation 1 - Minichart
Chinese firm Livzon secures control of Vietnam’s pharma giant Imexpharm in $228 mln deal - Theinvestor
Why Seagate Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Unusual VolumeStock ScreenerNews - Finviz
CPHI Technical Analysis & ETF Price Forecast - Intellectia AI
EBITDA per share of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
EBIT per share of China Pharma Holdings, Inc. – MUN:XQJ0 - TradingView
Regeneron CEO Defends Pharma, Warns China Will ‘Pass Us Right By’ After Announcing Free Gene Therapy For Hearing Loss - Stocktwits
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by China Universal Asset Management Co. Ltd. - MarketBeat
Shuttle Pharma (SHPH) proxy asks investors to OK major reverse split range - Stock Titan
China Pharma (CPHI) Stock Dividend Analysis (+1.54%) 2026-04-16Price Action - Cổng thông tin điện tử tỉnh Lào Cai
China Pharma Holdings, Inc. (CPHI) - Minichart
Trading Recap: Does ALLT have strong EBITDA margins2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
Aug Sentiment: Why is Alexanders Inc stock going downProduct Launch & Weekly High Momentum Picks - baoquankhu1.vn
Is China Pharma (CPHI) Stock a Growth Play | Price at $0.65, Up 0.62%Community Watchlist - newser.com
symbol__ Stock Quote Price and Forecast - CNN
US Market Recap: Can PBHC generate free cash flowLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Is China Pharma (CPHI) Stock defensive in downturns | Price at $0.60, Down 2.42%Attention Stocks - newser.com
Ascentage Pharma Group International (NASDAQ:AAPG) Raised to "Strong-Buy" at China Intl Cap - MarketBeat
Is Quantum-Si Incorporated (QSI) Stock tied to economic cycles | QSI Q4 Earnings: Beats Estimates by $0.04Sell Rating - Xã Châu Thành
Market Catalysts: Is China Pharma Holdings Incs ROE strong enough2026 Volume Leaders & High Conviction Trade Alerts - baoquankhu1.vn
Earnings Risk: Can China Pharma Holdings Inc expand its profit marginsVolume Spike & Low Drawdown Trading Strategies - baoquankhu1.vn
Can Merchants (MBINL) Stock Beat Estimates | Price at $24.30, Up 1.12%Resistance Breakout - Xã Thanh Hà
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison - Defense World
CUPR PE Ratio & Valuation, Is CUPR Overvalued - Intellectia AI
DRMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
China Pharma Holdings, Inc. (XQJ.DE) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
China Pharma Holdings, Inc. (XQJ.DE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
CPHI Q3 2011 Earnings: China Pharma Holdings Inc. misses EPS estimates - Cổng thông tin điện tử tỉnh Lào Cai
China Pharma Delays 10-K but Shows Narrowing Losses - The Globe and Mail
China Pharma Holdings 2026 Annual Report: Strategic Focus on Generic Drugs, Market Expansion, and Innovation in China’s Pharmaceutical Industry - Minichart
China Pharma Holdings Files For Non-Timely 10-K With US SEC - TradingView
China Pharma Holdings 10-K: Revenue $4.14M, Loss per Share $(0.74) - TradingView — Track All Markets
China Pharma (NYSE American: CPHI) details 2025 losses and China policy risks - Stock Titan
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Buy Signal: Can China Pharma Holdings Inc keep up with sector leadersBull Run & Trade Opportunity Analysis - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
US pharma giant reaches $2.75 billion deal with China-based biotech company for AI-developed drugs - Yahoo Finance
Risk Report: How does China Pharma Holdings Inc perform in inflationary periods2026 Growth vs Value & Capital Protection Trade Alerts - baoquankhu1.vn
China NT Pharma Group Announces Reduced Net Loss for 2025 After One-Off Non-Cash Gain – Profit Warning Update - Minichart
Market Outlook: How does China Pharma Holdings Inc perform in inflationary periodsForecast Cut & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Aug Technicals: Can China Pharma Holdings Inc expand into new marketsQuarterly Investment Review & Stepwise Trade Signal Implementation - baoquankhu1.vn
Jobs Data: Is China Pharma Holdings Incs ROE strong enough2026 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Drivers: Can China Pharma Holdings Inc keep up with sector leadersTrade Analysis Report & Low Volatility Stock Recommendations - baoquankhu1.vn
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
If You Invested $1,000 in China Pharma (CPHI) - Stock Titan
Quarterly Trades: How does China Pharma Holdings Inc perform in inflationary periodsMarket Sentiment Report & AI Enhanced Execution Alerts - baoquankhu1.vn
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative - simplywall.st
Market Outlook: Will China Pharma Holdings Inc be affected by tariffs2026 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback - simplywall.st
Investment Recap: How correlated is NCDL to the S P500Long Setup & Weekly Momentum Stock Picks - baoquankhu1.vn
Bearish Setup: How does China Pharma Holdings Inc perform in inflationary periods2026 Winners & Losers & Low Drawdown Investment Strategies - baoquankhu1.vn
0.73%
3.85%
자본화:
|
볼륨(24시간):